-transparent.png){kind=logo}
Insulin initiates its pleiotropic effects by activating the insulin receptor tyrosine kinase to phosphorylate several intracellular proteins. Recent studies have demonstrated that phosphotyrosine residues bind specifically to proteins that contain src homology 2 (SH2) domains, and that this interaction mediates the regulation of multiple intracellular signaling pathways. This article reviews recent progress in elucidating the detailed pathways that lead from the insulin receptor to the ultimate biologic actions of insulin.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
M J Quon, and
A J Butte, and
S I Taylor
April 2008,
Sheng li ke xue jin zhan [Progress in physiology],
M J Quon, and
A J Butte, and
S I Taylor
April 2006,
Experimental cell research,
M J Quon, and
A J Butte, and
S I Taylor
December 2002,
The Journal of biological chemistry,
M J Quon, and
A J Butte, and
S I Taylor
August 1998,
IDrugs : the investigational drugs journal,
M J Quon, and
A J Butte, and
S I Taylor
June 1995,
Biochemistry,
M J Quon, and
A J Butte, and
S I Taylor
April 2008,
Organogenesis,
M J Quon, and
A J Butte, and
S I Taylor
October 2000,
Trends in endocrinology and metabolism: TEM,
M J Quon, and
A J Butte, and
S I Taylor
January 2010,
Cell,
M J Quon, and
A J Butte, and
S I Taylor
February 1994,
The Journal of biological chemistry,
M J Quon, and
A J Butte, and
S I Taylor
March 1996,
Trends in endocrinology and metabolism: TEM,
